Patients with a previously harvested hematopoietic stem cells while in complete or partial remission or in the case of patients with stable or refractory disease are undergoing autologous transplantation because it has been recommended by their treating physician as representing their best treatment option with a goal of at minimum of 2 x 10^6 cluster of differentiation CD 34+ peripheral primed stem cells per kilogram of actual body weight 